Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "MicroRNA Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.
This report thoroughly examining the burgeoning global microRNA market, which continues to thrive with anticipated high growth rates through the forecast period of 2023 to 2028. As microRNAs emerge as pivotal elements in genetic regulation, their applications extend across clinical diagnostics, personalized medicine, and a multitude of therapeutic areas.
Surge in MicroRNA Clinical Trials and Technological Advances
The ongoing expansion of microRNA clinical trials represents a significant trend in the market, contributing to substantial growth rates. These small, non-coding RNA molecules are increasingly recognized for their intricate role in gene expression across diverse organisms. Technological breakthroughs and the advent of novel products have ensured continuous momentum in this sector, resulting in a market evaluation which stood at US$1.41 billion in 2021.
Rising Prevalence of Chronic Diseases Driving Market Expansion
The microRNA market is further invigorated by the escalating prevalence of chronic illnesses, especially cancer. With an approximate 10 million mortalities in 2020 attributed to cancer, according to World Health Organization data, the demand for diagnostic and therapeutic innovations remains robust. MicroRNAs are at the forefront of this revolution, heralding a new era of disease management and patient-specific treatment modalities.
North America at the Forefront of Market Advancements
With a formidable share in the microRNA market, North America's contribution is augmented by progressive regulatory frameworks, the mounting toll of chronic ailments, and a surge in scientific investigations. Recognized entities such as Thermo Fisher Scientific and BioGenex are propelling advances within the region, emphasizing the market's dynamic nature.
Cutting-edge Research in Diagnostic Applications
Transformative diagnostic applications are a focal point of current research, as exemplified by Craif's recent introduction of a urinary microRNA test for breast cancer, part of their miSignal® series. Similarly, MiRXES is spearheading the CADENCE project, poised to revolutionize early detection for up to nine types of cancer.
Growth Opportunities in Diverse Disciplines
Beyond clinical diagnostics, microRNAs are exploring frontiers across veterinary medicine, agriculture, and environmental monitoring, heralding new vistas of research and product development.
Market Segmentation Insight
The microRNA market is segmented by type, application, end-use, and geography, offering a granular analysis of each market silo. Various health conditions including infectious diseases, cardiovascular and neurological disorders, alongside cancer research, are witnessing keen investments and research focus.
The in-depth research publication delves into these market dynamics, constraints, and the geographical growth patterns, underlining the pivotal role of microRNAs in contemporary and future medical science. Stakeholders and market participants will find the report's assessments and projections critical in formulating strategic decisions and navigating the evolving landscape of the microRNA market.
Pivotal Market Players and Advancements
New strategic developments by prominent market players further underscore the innovative spirit within the microRNA sector. The report's analysis of key player strategies offers insights into the advancements shaping the market's trajectory.
As precision medicine and molecular diagnostics are increasingly intertwined with microRNA research, the global market is set to witness profound growth and transformation. This publication available sheds light on this intricate market, analyzing the evolving trends and forecasting the path ahead.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 140 |
| Forecast Period | 2021-2028 |
| Estimated Market Value (USD) in 2021 | $1.41 Billion |
| Forecasted Market Value (USD) by 2028 | $4.54 Billion |
| Compound Annual Growth Rate | 18.1% |
| Regions Covered | Global |
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Horizon Discovery Ltd.
- QIAGEN
- BioGenex
- GeneCopoeia, Inc.
- NanoString
- Quantabio
- SeqMatic LLC
- OriGene Technologies, Inc.
- Illumina, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/l9u9tk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
